Christopher R. Cline, CFO: Travere Therapeutics TVTX Sell · Filed 25/01/23

Trade details

Type: Insider sale
Amount: $16,383.1
Shares · price: 865 sh · $18.94 a share
Held after: 73,730 sh
Stock: Travere Therapeutics TVTX
Person: Christopher R. ClineCFO
Trade date: 25/01/22
Filed: 25/01/23
Days to filing: 1 days

Sold 1.2% of holdings

Share of holding sold: 1.2%

Travere Therapeutics trades, last 26 weeks

What else happened in Travere Therapeutics around then

Filed or reported within 30 days of the trade day · 24/12/23~25/02/21

Christopher R. Cline's recent trades

Christopher R. ClineCFO
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$3.3M
50,508 sh
$3.3M
Filed 09/15
Traded 09/15
Christopher R. ClineCFO
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$101.7K
2,181 sh
$101.7K
Filed 05/06
Traded 05/05
Christopher R. ClineCFO
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$13.6K
310 sh
$13.6K
Filed 05/06
Traded 05/06
Christopher R. ClineCFO
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$13.6K
310 sh
$13.6K
Filed 05/06
Traded 05/06
Christopher R. ClineCFO
Planned saleTravere Therapeutics
Planned sale
Travere Therapeutics
TVTX
$101.7K
2,181 sh
$101.7K
Filed 05/05
Traded 05/05